Xenon Pharmaceuticals (XENE) EPS (Basic) (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly EPS (Basic) of -$1.17 for Q1 2026, down 41.68% year-over-year from -$2.01 in Q1 2025, and up 19.02% quarter-over-quarter from -$1.45 in Q4 2025.
Xenon Pharmaceuticals (XENE) EPS (Basic) (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported EPS (Basic) for 14 consecutive years, with -$1.17 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 41.68% year-over-year to -$1.17; the TTM figure through Mar 2026 stood at -$4.49 (down 40.64% YoY), while the FY2025 annual figure was -$4.48, down 49.01% from the prior year.
- EPS (Basic) grew to -$1.17 in Q1 2026 per XENE's latest filing, from -$1.45 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.35 in Q1 2022 and bottomed at -$1.45 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.8 across 5 years, with a median of -$0.73 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) grew 15.23% — and 2023, when it sank 79.78%.
- Xenon Pharmaceuticals' EPS (Basic) stood at -$0.62 in 2022, then decreased by 8.35% to -$0.67 in 2023, then declined by 26.06% to -$0.84 in 2024, then sank by 71.52% to -$1.45 in 2025, then gained by 19.02% to -$1.17 in 2026.
- Business Quant data shows XENE's EPS (Basic) at -$1.17 in Q1 2026, -$1.45 in Q4 2025, and -$1.15 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | -1.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 |
| Mar 31, 2026 | -1.17 |
| Dec 31, 2025 | -1.45 |
| Sep 30, 2025 | -1.15 |
| Jun 30, 2025 | -1.07 |
| Mar 31, 2025 | -0.83 |
| Dec 31, 2024 | -0.84 |
| Sep 30, 2024 | -0.81 |
| Jun 30, 2024 | -0.75 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -0.67 |
| Sep 30, 2023 | -0.73 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.63 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.57 |
| Sep 30, 2021 | -0.37 |